This paper provides an empirical assessment of the effects of age and baseline health on willingness to pay(WTP) for mortalityrisk reductions byreporting the results of two contingent valuation surveys: one administered in Hamilton, Ontario and the other to a national sample of US residents. Respondents for both surveys were limited to persons aged 40 years and older to examine the impact of age on WTP.